title: Imaging the renin-angiotensin system: an important target of anti-hypertensive therapy.
abstract: Multiphoton fluorescence microscopy allows visualization, manipulation, and quantification of the structure-function relationships between pharmacological interventions and their physiological effects. The application of these methods to live animals permits direct observation of acute physical responses that lack chemically detectable signals in the blood or urine and would otherwise remain unknown. With the use of special fluorescent dyes, chemical/hormonal responses may also be detected. The delivery and site-specific effects of drugs can be monitored in real-time. The capacity to simultaneously visualize both proximal and distal segments of the nephron permits observation of the dynamic processes within the living kidney and a quantitative assessment of the various operations. Consequently, a clinically valuable and pending application for multi-photon microscopy will be to provide real-time, quantitative imaging of basic organ functions and their responses to therapeutic intervention. Imaging of the intra-renal renin content and enzymatic activity of renin in situ and in real-time is a new, more informative measure of RAS activity. Direct visualization of the molecular and cellular components of renin release signals and the interactions between the vascular endothelium, tubular epithelium, local mediators, and the renin producing cells provides great insight for drug development. Examples of how the effects of various RAS inhibitors can be visualized in the intact kidney are provided: including angiotensin converting enzyme inhibition (captopril), angiotensin II type 1 receptor blockade (olmesartan), and renin inhibition (aliskiren). The site-specific actions of diuretics, like furosemide, have also been visualized. Quantitative imaging of basic renal functions in health and disease can provide key information to assess the delivery and effects of pharmaceutical interventions.
authors.affiliation: Department of Physiology, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.
authors.forename: Jung Julie
authors.initials: JJ
authors.lastname: Kang
authors.forename: Ildikó
authors.initials: I
authors.lastname: Toma
authors.forename: Arnold
authors.initials: A
authors.lastname: Sipos
authors.forename: Fiona
authors.initials: F
authors.lastname: McCulloch
authors.forename: János
authors.initials: J
authors.lastname: Peti-Peterdi
mesh_terms: D000818:Animals; D000959:Antihypertensive Agents / Q000493:pharmacokinetics*; D006977:Hypertension, Renal / Q000503:physiopathology; D007668:Kidney / Q000187:drug effects / Q000502:physiology / Q000503:physiopathology; D036641:Microscopy, Fluorescence, Multiphoton; D012083:Renin / Q000378:metabolism; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology*
chemical_list: D000959:Antihypertensive Agents; D012083:Renin